Gerlach MM, Stelling-Germani A, Wu CT, Newrzela S, Döring C, Vela V, Müller A, Hartmann S, Tzankov A. SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy. Haematologica 2021; 106(2):619-621; https://doi.org/10.3324/haematol.2020.249276.